The Efficacy of an Immunoisolating Membrane System for Islet Xenotransplantation in Minipigs

Developing a device that protects xenogeneic islets to allow treatment and potentially cure of diabetes in large mammals has been a major challenge in the past decade. Using xenogeneic islets for transplantation is required in light of donor shortage and the large number of diabetic patients that qualify for islet transplantation. Until now, however, host immunoreactivity against the xenogeneic graft has been a major drawback for the use of porcine islets. Our study demonstrates the applicability of a novel immunoprotective membrane that allows successful xenotransplantation of rat islets in diabetic minipigs without immunosuppressive therapy. Rat pancreatic islets were encapsulated in highly purified alginate and integrated into a plastic macrochamber covered by a poly-membrane for subcutaneous transplantation. Diabetic Sinclair pigs were transplanted and followed for up to 90 days. We demonstrated a persistent graft function and restoration of normoglycemia without the need for immunosuppressive therapy. This concept could potentially offer an attractive strategy for a more widespread islet replacement therapy that would restore endogenous insulin secretion in diabetic patients without the need for immunosuppressive drugs and may even open up an avenue for safe utilization of xenogeneic islet donors.

[1]  P. de Vos,et al.  Enhanced Oxygen Supply Improves Islet Viability in a New Bioartificial Pancreas , 2013, Cell transplantation.

[2]  A. Shapiro,et al.  Update on islet transplantation. , 2012, Cold Spring Harbor perspectives in medicine.

[3]  Nicole A. Turgeon,et al.  Improvement in Outcomes of Clinical Islet Transplantation: 1999–2010 , 2012, Diabetes Care.

[4]  B. Hering,et al.  Potent Induction Immunotherapy Promotes Long‐Term Insulin Independence After Islet Transplantation in Type 1 Diabetes , 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[5]  K. Fujinaga,et al.  Functional characterization of a human cyclin T1 mutant reveals a different binding surface for Tat and HEXIM1. , 2012, Virology.

[6]  G. Warnock,et al.  Reduced Progression of Diabetic Microvascular Complications With Islet Cell Transplantation Compared With Intensive Medical Therapy , 2011, Transplantation.

[7]  Denis Dufrane,et al.  Alginate Macroencapsulation of Pig Islets Allows Correction of Streptozotocin-Induced Diabetes in Primates up to 6 Months Without Immunosuppression , 2010, Transplantation.

[8]  S. Bornstein,et al.  A Novel Device for Islet Transplantation Providing Immune Protection and Oxygen Supply , 2010, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[9]  S. Bornstein,et al.  Islet Versus Pancreas Transplantation in Type 1 Diabetes: Competitive or Complementary? , 2010, Current diabetes reports.

[10]  Stefan R Bornstein,et al.  Agonist of growth hormone-releasing hormone as a potential effector for survival and proliferation of pancreatic islets , 2010, Proceedings of the National Academy of Sciences.

[11]  J. Bluestone,et al.  2007 Update on Allogeneic Islet Transplantation from the Collaborative Islet Transplant Registry (CITR) , 2009, Cell transplantation.

[12]  P. de Vos,et al.  Adsorption of human immunoglobulin to implantable alginate-poly-L-lysine microcapsules: effect of microcapsule composition. , 2009, Journal of biomedical materials research. Part A.

[13]  R. Kurth,et al.  No in vivo infection of triple immunosuppressed non‐human primates after inoculation with high titers of porcine endogenous retroviruses * , 2009, Xenotransplantation.

[14]  Jean-Luc Dulong,et al.  A theoretical study of oxygen transfer including cell necrosis for the design of a bioartificial pancreas , 2007, Biotechnology and bioengineering.

[15]  Wolfgang Moritz,et al.  Superiority of Small Islets in Human Islet Transplantation , 2007, Diabetes.

[16]  Philippe Morel,et al.  International trial of the Edmonton protocol for islet transplantation. , 2006, The New England journal of medicine.

[17]  Denis Dufrane,et al.  Six-Month Survival of Microencapsulated Pig Islets and Alginate Biocompatibility in Primates: Proof of Concept , 2006, Transplantation.

[18]  O. Källskog,et al.  Duct ligation and pancreatic islet blood flow in rats: physiological growth of islets does not affect islet blood perfusion. , 2005, European journal of endocrinology.

[19]  J. Schrezenmeir,et al.  Effect of the immunosuppressive regime of Edmonton protocol on the long-term in vitro insulin secretion from islets of two different species and age categories. , 2005, Toxicology in vitro : an international journal published in association with BIBRA.

[20]  A. Vasconcellos,et al.  Transplantation of micro- and macroencapsulated piglet islets into mice and monkeys. , 2005, Transplantation proceedings.

[21]  E. Kitano,et al.  A study of the xenoantigenicity of adult pig islets cells , 2004, Xenotransplantation.

[22]  R. van Schilfgaarde,et al.  Response of Encapsulated Rat Pancreatic Islets to Hypoxia , 2003, Cell Transplantation.

[23]  E. Montanya,et al.  Beta-cell death and mass in syngeneically transplanted islets exposed to short- and long-term hyperglycemia. , 2002, Diabetes.

[24]  J. Lakey,et al.  Preclinical Development of the Islet Sheet , 2001, Annals of the New York Academy of Sciences.

[25]  D. Gray.  An Overview of the Immune System with Specific Reference to Membrane Encapsulation and Islet Transplantation , 2001, Annals of the New York Academy of Sciences.

[26]  P. Liss,et al.  Markedly decreased oxygen tension in transplanted rat pancreatic islets irrespective of the implantation site. , 2001, Diabetes.

[27]  T. Lohmann,et al.  Diabetes mellitus and islet cell specific autoimmunity as adverse effects of immunsuppressive therapy by FK506/tacrolimus. , 2000, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[28]  D. Gray.  Encapsulated islet cells: the role of direct and indirect presentation and the relevance to xenotransplantation and autoimmune recurrence. , 1997, British medical bulletin.

[29]  A. Sun,et al.  Normalization of diabetes in spontaneously diabetic cynomologus monkeys by xenografts of microencapsulated porcine islets without immunosuppression. , 1996, The Journal of clinical investigation.

[30]  L. Jansson.  The regulation of pancreatic islet blood flow. , 1994, Diabetes/metabolism reviews.

[31]  R. Oriol,et al.  Clinical potential of xenotransplantation. , 1994, Transplantation proceedings.